[1]廉江平,丰 航,方志远,等.EMIT与HPLC法测定肾移植术后患者体内霉酚酸血药浓度结果比较[J].现代检验医学杂志,2017,32(03):74-78.[doi:10.3969/j.issn.1671-7414.2017.03.020]
LIAN Jiang-ping,FENG Hang,FANG Zhi-yuan,et al.Research on Results of Plasma Mycophenolic Acid Concentration Det
ected
by EMIT and HPLC in the Patients after Renal Transplantation[J].Journal of Modern Laboratory Medicine,2017,32(03):74-78.[doi:10.3969/j.issn.1671-7414.2017.03.020]
点击复制
EMIT与HPLC法测定肾移植术后患者体内霉酚酸血药浓度结果比较(
)
《现代检验医学杂志》[ISSN:/CN:]
- 卷:
-
第32卷
- 期数:
-
2017年03期
- 页码:
-
74-78
- 栏目:
-
论著
- 出版日期:
-
2017-05-25
文章信息/Info
- Title:
-
Research on Results of Plasma Mycophenolic Acid Concentration Det
ected
by EMIT and HPLC in the Patients after Renal Transplantation
- 文章编号:
-
1671-74
14(2017)03-074-05
- 作者:
-
廉江平; 丰 航; 方志远; 李小川
-
陕西省人民医院药
学部,西安 710068
- Author(s):
-
LIAN Jiang-ping; FENG Hang; FANG Zhi-yuan; LI Xiao-c
huan
-
Department of Pharmacy,Shaanxi Provincial People’s Hospital,X
i’an 710068,China
-
- 关键词:
-
霉酚酸; 酶扩大免疫法; 高效液相色谱法; 一致性
- 分类号:
-
R699.2;R969.1
- DOI:
-
10.3969/j.issn.1671-7414.2017.03.020
- 文献标志码:
-
A
- 摘要:
-
目的 采用Pearson相关分析和Bland-Altman图研究酶扩大
免疫法(EMIT)和高效液相色谱法(HPLC)检测霉酚酸(MPA)血药浓度的相关性和一致性。〖HT5
”H〗方法 收集2014年10月~2015年12月95例采用霉酚酸治疗的肾移植患者血
样435份,采用两种方法测定同份样本中的MPA,并将测定结果分为两个浓度水平,在各浓度
水平的测定结果间用SPSS13.0进行配对t检验及Pearson相关分析;绘制Bland-Altman
一致性限度考察两种方法测定结果的一致性。结果 EMIT法测定结果
高于HPLC法,两者间存在具有统计学意义的正偏差(20.94%±14.42%,P<0.001),两
方法在不同的浓度水平具有良好的相关关系(r>0.98)和一致性。结论 〖H
T5”K〗EMIT法测定MPA血药浓度结果较HPLC法偏高,两种方法所得结果间具有良好的相关性
和一致性。在MPA治疗药物监测时应对两种方法建立不同的治疗窗范围。
- Abstract:
-
Objective The correlation and agreement of myco
phenolic acid (MPA) plasma concentrations that detected by enzyme extended immun
oassay (EMIT) and high performance liquid chromatography (HPLC) were studied usi
ng Pearson’s correlation and Bland-Altman plots.METHODS 435 plasma samples we
re collected from 95 renal transplant patients who were treated with MPA from Oc
tober 2014 to December 2015.The MPA plasma concentrations were simultaneously m
easured by EMIT and HPLC respectively,and the results were divided into two le
vels.Paired t test and Pearson’s correlation were performed using SPSS13.
0 to evaluate the relationships between the results in each level.The Bland-Al
tman plot was used to assess the agreement of the results of two methods.〖WT5
”HZ〗Results Higher concentrations were obtained with EMIT,there w
as a significant positive bias of EMIT for MPA(20.94%±14.42%,P<0.001).
Pearson’s correlation analysis and Bland-Altman analysis showed that the resul
ts from different methods presented good correlation (r>0.98) and agreement
.Conclusion The results of EMIT were higher than that of
HPLC.There were good correlation and agreement between the two methods.The di
fferences between EMIT and HPLC suggest that different therapeutic window should
be set up when the two methods are used for MPA therapeutic drug monitoring.
参考文献/References:
[1] 中华医学会器官移植学分会,中国医师协会器官移植医师分会. 中国肾移
植受者免疫抑制治疗指南(2016版)[J].器官移植,2016,7(5):327-331.
Chinese Society of Organ Transplantation,Chinese Medical Doctor As
sociation of Organ Transplantation.Guideline on immunosuppressive therapy of r
ecipients with renal transplantation in China(2016 edition)[J].Organ Transpl
antation,2016,7(5):327-331.
[2] Van Hest RM,Van Gelder T,Bouw R,et al.Time-dependent clearance
of mycophenolic acid in renal transplant recipients[J].Br J Clin Pharmacol,2
007,63 (6):741-752.
[3] Van Hest RM,Mathot RA,Pescovitz MD,et al.Explaining variabili
ty in mycophenolic acid exposure to optimize mycophenolate mofetil dosing:a pop
ulation pharmacokinetic meta-analysis of mycophenolic acid in renal transplant
recipients[J].J Am Soc Nephrol,2006,17(3):871-880.
[4] Staatz CE,Tett SE.Pharmacology and toxicology of mycophenolate in organ
transplant recipients:an update[J].Arch Toxicol,2014,88(7):1351-1389.
[5] Van Gelder T,Le Meur Y,Shaw LM,et al.Therapeutic drug monitoring
of mycophenolate mofetil in transplantation[J].Ther Drug Monit,2006,28(2)
:145-154.
[6] Pithukpakorn M,Tiwawanwong T,Lalerd Y,et al.Mycophenolic a
cid AUC in Thai kidney transplant recipients receiving low dose mycophenolate an
d its association with UGT2B7 polymorphisms[J].Pharmgenomics Pers Med,2014(
7):379-385.
[7] Tornatore KM,Meaney CJ,Wilding GE,et al.Influence of sex and
race on mycophenolic acid pharmacokinetics in stable African American and Caucas
ian rena
l transplant recipients[J].Clin Pharmacokinet,2015,54(4):423-434.
[8] Sommerer C,Müller-krebs S,Schaier M,et al.Pharmacokinetic and pharm
acodynamic analysis of enteric-coated mycophenolate sodium:limited sampling st
rategies and clinical outcome in renal transplant patients[J].Br J Clin Pharm
acol,2010,69(4):346-357.
[9] Fleming DH,Mathew BS,Prasanna S,et al.A possible simplification for t
he estimation of area under the curve (AUC0-12) of enteric-coated mycophenolat
e sodium in renal transplant patients receiving tacrolimus[J].Ther Drug Monit
,2011,33(2):165-170.
[10] Prémaud A,Rousseau A,Picard N,et al.Determination of mycoph
enolic acid plasma levels in renal transplant recipients co-administered siroli
mus:comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid
chromatography-tandem mass spectrometry[J].Ther Drug Monit,2006,28(2):274
-277.
[11] Chen B,Gu Z,Chen H,et al.Establishment of high-performance liquid c
hromatography and enzyme multiplied immunoassay technology methods for determina
tion of free mycophenolic acid and its application in Chinese liver transplant r
ecipients[J].Ther Drug Monit,2010,32(5):653-660.
[12] Kunicki PK,Pawi Ski T,Boczex A,et al.A comparison of the immunoch
emical methods,PETINIA and EMIT,with that of HPLC-UV for the routine monitori
ng of mycophenolic acid in heart transplant patients[J].Ther Drug Monit,2015
,37(3):311-318.
[13] 廉江平,李小川,张 鹏,等.EMIT与FPIA法测定肾移植术后患者体内环孢素A血
药浓度结果比较[J].安徽医药,2013,17(12):2039-2041.
Lian JP,Li XC,Zhang P,et al.Comparison of the result of the two method
s to determine the concentration of cyclosporine A in patients after renal trans
plantation[J].Anhui Medical and Pharmaceutical Journal,2013,17(12):2039-2
041.
[14] Clinical and Laboratory Standards Institute.Measurement Procedure Comp
arison and Bias Estimation Using Patient Samples;Approved Guideline[S].Wayne
,PA:CISI EPOP-A3,2013.
[15] 曾宪飞,李军民,谈 昀,等.不同评价方案在临床比对试验应用的方法学探讨[
J].现代检验医学杂志,2012,27(2):66-69.
Zeng XF,Li JM,Tan Y,et al.Method comparation study using different eva
luation criteria[J].Journal of Modem Laboratory Medicine,2012,27(2):66-69
.
备注/Memo
- 备注/Memo:
-
作者简介:廉江平(1971-),男,硕士,副主任药师,主要研究方向:临床药
学及体内药物分析,E-mail:ljp2075@163.com。
通讯作者:丰 航(1976-),女,本科,主要研究方向:医院药学
,E-mail:277312304@qq.com。
更新日期/Last Update:
2017-06-25